Menu Search
Equities

Cannara Biotech Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
LOVE:CVE

Cannara Biotech Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)1.80
  • Today's Change0.00 / 0.00%
  • Shares traded108.04k
  • 1 Year change+42.86%
  • Beta0.2808
Data delayed at least 15 minutes, as of Feb 13 2026 20:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Canadian markets. The Company operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. It owns two mega cultivation facilities based in Quebec spanning over 1,650,000 square feet and provides up to 100 000 kilograms of annualized cultivation output. It operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives mainly for the Canadian market. The Real estate operations is related to the Farnham and Valleyfield building. The Company's brand portfolio includes Tribal, Nugz, and Orchid CBD. Tribal delivers grade cannabis products. Orchid CBD is a wellness brand that provides CBD-rich cannabis.

  • Revenue in CAD (TTM)112.36m
  • Net income in CAD11.81m
  • Incorporated2017
  • Employees452.00
  • Location
    Cannara Biotech IncSuite 2050 - 1055, West Georgia StreetVANCOUVER V6E 3P3CanadaCAN
  • Phone+1 (514) 913-9136
  • Fax+1 (514) 913-9136
  • Websitehttps://www.cannara.ca/en/
More ▼

Institutional shareholders

0.23%Per cent of shares held by top holders
HolderShares% Held
AdvisorShares Investments LLCas of 31 Dec 2025215.75k0.23%
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.